BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+3.32%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.17B
AUM Growth
+$1.17B
(+4.3%)
Cap. Flow
+$39M
Cap. Flow
% of AUM
3.32%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
STAAR Surgical
STAA
|
$39.7M |
Top Sells
| 1 |
Monster Beverage
MNST
|
$762K |
Sector Composition
| 1 | Consumer Staples | 41.68% |
| 2 | Healthcare | 31.91% |
| 3 | Industrials | 16.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Monster Beverage
MNST
$60.9B
| $489M | 41.68% | 8,488,017 -13,219 | -0.2% | -$762K |
|
|
2
STAAR Surgical
STAA
$1.36B
| $329M | 28.03% | 10,537,835 +1,273,408 | +14% | +$39.7M |
|
3
Axon Enterprise
AXON
$58.7B
| $196M | 16.73% | 760,062 | – | – |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $114M | 9.68% | 566,000 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $38.1M | 3.25% | 34,935,485 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $6.27M | 0.53% | 2,509,066 | – | – |
|
7
Serina Therapeutics
SER
$54.5M
| $1.15M | 0.1% | 2,997,156 | – | – |
|